- $172.35m
- $167.26m
- $109.43m
Optimizerx Corp Expected To Post Earnings Of 26 Cents A Share: Earnings Preview
Optimizerx Corp Expected To Post Earnings Of 26 Cents A Share: Earnings Preview
Brief: OptimizeRx Announces Gus Halas Is Retiring From His Position As Chairperson Of Board
U.S. RESEARCH ROUNDUP-Chesapeake Utilities, Duke Energy, McKesson
U.S. STOCKS ON THE MOVE-ResMed, Revvity, Acuity Brands
OptimizeRx expects 2023 revenue to exceed its forecast, shares jump
Brief: Optimizerx Preannounces Select Expected 2023 Financials
Brief: Michael Weintraub Reports 7.4% Passive Stake In Optimizerx Corp As Of October 24
Brief: Optimizerx Corp QTRLY Net Loss Per Share Of $0.17
Optimizerx Corp Expected To Post Earnings Of 2 Cents A Share: Earnings Preview
Brief: OptimizeRx Announces Agreement To Acquire Medicx Health For $95 Million
Brief: OPTIMIZERx Q2 revenue USD 13.8 million
Optimizerx Corp Reports Results For The Quarter Ended In June: Earnings Summary
Optimizerx Corp Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: First Light Asset Management Reports 10.28% Passive Stake In Optimizerx
Brief: Optimizerx’S CEO Provides 2023 Mid year Strategic Update
Brief: Optimizerx Corp - GAAP Net Loss Totaled $6.4 Million Or $0.37 Per Basic And Diluted Shares Outstanding In First Quarter
Optimizerx Corp Reports Results For The Quarter Ended In March: Earnings Summary
Optimizerx Corp Expected To Post A Loss Of 8 Cents A Share: Earnings Preview